Related Experiment Video
Updated: Jun 4, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
N6-methyladenosine in 28S rRNA promotes oncogenic mRNA translation and tyrosine catabolism
Binbin Chen1, Li Li2, Ying Huang3
1State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China; Department of Clinical Nutrition, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
Abstract:
Aberrant N6-methyladenosine (m6A) modification on mRNA results in dysregulated mRNA translation and cancer progression; however, the role of m6A modification on rRNA remains unclear in cancers. Here, we show that ZCCHC4 and its mediated m6A modification on 28S rRNA are upregulated in various cancers and correlated with poor survival. Functionally, ZCCHC4 promotes intrahepatic cholangiocarcinoma (ICC) progression via its catalytic activity. Mechanistically, tether of the N6-adenineMIase domain of ZCCHC4 to the m6A site on 28S rRNA facilitates the binding of the zf-GRF-containing domain to eIF3G in the translation initiation complex and the binding of zf-DHHC-containing domain to the 3' UTR of mRNA, therefore facilitating mRNA circularization and translation. Further analysis reveals that HPD mediates ZCCHC4's functions on tyrosine catabolism and ICC progression, and targeting HPD inhibits ICC progression in vivo. Overall, our findings uncover insights underlying mRNA translation control and provide a molecular basis for targeting the ZCCHC4-HPD axis in ICC.
Insights
ZCCHC4-mediated m6A modification on 28S rRNA drives cancer progression. Targeting the ZCCHC4-HPD axis offers a new strategy for treating intrahepatic cholangiocarcinoma (ICC).
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Aberrant N6-methyladenosine (m6A) mRNA modification is linked to cancer progression.
- The role of m6A modification on ribosomal RNA (rRNA) in cancer remains largely unknown.
Purpose of the Study:
- To investigate the function of ZCCHC4 and its m6A modification on 28S rRNA in cancer, particularly intrahepatic cholangiocarcinoma (ICC).
- To elucidate the molecular mechanisms by which ZCCHC4 influences cancer progression and to identify potential therapeutic targets.
Main Methods:
- Analysis of ZCCHC4 and m6A levels in various cancer types.
- Functional studies using cell models and in vivo experiments to assess ZCCHC4's role in ICC progression.
- Mechanistic investigations into ZCCHC4's interaction with the translation initiation complex and mRNA 3' UTR.
Main Results:
- ZCCHC4 and its m6A modification on 28S rRNA are upregulated in cancers and associated with poor survival.
- ZCCHC4 promotes ICC progression through its catalytic activity.
- ZCCHC4 facilitates mRNA circularization and translation by interacting with eIF3G and mRNA 3' UTR.
- HPD mediates ZCCHC4's effects on tyrosine catabolism and ICC progression.
- Targeting HPD inhibits ICC progression in vivo.
Conclusions:
- ZCCHC4-mediated m6A modification on 28S rRNA is a key driver of cancer progression.
- The ZCCHC4-HPD axis represents a novel molecular mechanism regulating translation and tyrosine catabolism in ICC.
- Targeting the ZCCHC4-HPD axis holds therapeutic potential for ICC treatment.
Related Concept Videos
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Abnormal Proliferation
Nuclear Export of mRNA
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Nucleolus
Leaky Scanning

